Cargando…

The fragility index in 2010-2021 chronic lymphocytic leukemia randomized controlled trials

Detalles Bibliográficos
Autores principales:	Bagacean, Cristina, Ianotto, Jean-Christophe, Sritharan, Nanthara, Cymbalista, Florence, Berthou, Christian, Lévy, Vincent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology 2022
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753221/ https://www.ncbi.nlm.nih.gov/pubmed/34753170 http://dx.doi.org/10.1182/bloodadvances.2021006473

Ejemplares similares

Fragility index of positive phase II and III randomised clinical trials of treatments for hepatocellular carcinoma (2002–2022)
por: Sidali, Sabrina, et al.
Publicado: (2023)

DNA demethylation marks in chronic lymphocytic leukemia: it is time to let the cat out of the bag
por: Bagacean, Cristina, et al.
Publicado: (2017)

Humoral Response to mRNA Vaccines BNT162b2 and mRNA-1273 COVID-19 in Chronic Lymphocytic Leukemia Patients
por: Bagacean, Cristina, et al.
Publicado: (2021)

Humoral response to mRNA anti–COVID-19 vaccines BNT162b2 and mRNA-1273 in patients with chronic lymphocytic leukemia
por: Bagacean, Cristina, et al.
Publicado: (2022)

Resistance to complement activation, cell membrane hypersialylation and relapses in chronic lymphocytic leukemia patients treated with rituximab and chemotherapy
por: Bordron, Anne, et al.
Publicado: (2018)

17p deletion strongly influences rituximab elimination in chronic lymphocytic leukemia
por: Bagacean, Cristina, et al.
Publicado: (2019)

Combining cytogenetic and epigenetic approaches in chronic lymphocytic leukemia improves prognosis prediction for patients with isolated 13q deletion
por: Bagacean, Cristina, et al.
Publicado: (2017)

STIM1 at the plasma membrane as a new target in progressive chronic lymphocytic leukemia
por: Debant, Marjolaine, et al.
Publicado: (2019)

Simulated patient and role play methodologies for communication skills and empathy training of undergraduate medical students
por: Bagacean, Cristina, et al.
Publicado: (2020)

Alterations in DNA methylation/demethylation intermediates predict clinical outcome in chronic lymphocytic leukemia
por: Bagacean, Cristina, et al.
Publicado: (2017)

Nurselike cells sequester B cells in disorganized lymph nodes in chronic lymphocytic leukemia via alternative production of CCL21
por: Zaaboub, Rim, et al.
Publicado: (2022)

Patients’ Perceived Importance of Medication and Adherence in Polypharmacy, a Quantitative, Cross-Sectional Study Using a Questionnaire Administered in Three Doctors’ Private Practices in France
por: Reach, Gérard, et al.
Publicado: (2023)

Infection by H1N1 flu virus revealing T-cell acute lymphoid leukaemia: about two cases
por: Lefevre, Guillaume, et al.
Publicado: (2010)

Exudative pericarditis in the evolution of a diffuse large B-cell lymphoma
por: Bagacean, Cristina, et al.
Publicado: (2015)

Atypical aleukemic presentation of large granular lymphocytic leukemia: a case report
por: Bagacean, Cristina, et al.
Publicado: (2016)

Rapid and complete response to idelalisib in a case of Richter syndrome
por: Bagacean, Cristina, et al.
Publicado: (2019)

Immuno-regulatory malignant B cells contribute to Chronic Lymphocytic Leukemia progression
por: Mékinian, Arsène, et al.
Publicado: (2023)

TP53 aberrations in chronic lymphocytic leukemia: an overview of the clinical implications of improved diagnostics
por: Campo, Elias, et al.
Publicado: (2018)

Acute dyspnoea and single tracheal localisation of mantle cell lymphoma
por: Ianotto, Jean-Christophe, et al.
Publicado: (2010)

ESHAP chemotherapy is efficient in refractory/relapsed primary central nervous system lymphoma: report of four cases
por: Ungur, Rodica, et al.
Publicado: (2015)

Non-adherence to treatment with cytoreductive and/or antithrombotic drugs is frequent and associated with an increased risk of complications in patients with polycythemia vera or essential thrombocythemia (OUEST study)
por: Le Calloch, Ronan, et al.
Publicado: (2018)

Therapeutic activity of two xanthones in a xenograft murine model of human chronic lymphocytic leukemia
por: Loisel, Séverine, et al.
Publicado: (2010)

Ultra-Wide-Field Fluorescein Angiography Assessment of Non-Perfusion in Patients with Diabetic Retinopathy Treated with Anti-Vascular Endothelial Growth Factor Therapy
por: Morel, Jean-Baptiste, et al.
Publicado: (2023)

ODP090 Fragility Fractures and Osteoporosis Screening in Patients with Chronic Lymphocytic Leukemia
por: Petty, Lloyd, et al.
Publicado: (2022)

Hemorrhagic Cystitis due to BK Reactivation in a Young Female Treated for Hodgkin-Disease
por: Le Calloch, R., et al.
Publicado: (2011)

Diagnosis and Treatment of Chronic Lymphocytic Leukemia: Recommendations of the French CLL Study Group (FILO)
por: Quinquenel, Anne, et al.
Publicado: (2020)

How Fragile Are the Results of a Trial? The Fragility Index
por: Dettori, Joseph R., et al.
Publicado: (2020)

Fragility index and fragility quotient in randomized clinical trials
por: Garcia, Marcos Vinicius Fernandes, et al.
Publicado: (2023)

PB2697: LONG TERM PEJORATIVE IMPACT OF LENALIDOMIDE MAINTENANCE ON HEALTH-RELATED QUALITY OF LIFE IN CHRONIC LYMPHOCYTIC LEUKEMIA. ANCILLARY STUDY OF THE PHASE III CLL6-RESIDUUM TRIAL
por: Wasse, Stephane, et al.
Publicado: (2023)

PD-1/PD-L1 expression in anal squamous intraepithelial lesions
por: Bucau, Margot, et al.
Publicado: (2020)

Closed-loop control of a fragile network: application to seizure-like dynamics of an epilepsy model
por: Ehrens, Daniel, et al.
Publicado: (2015)

Impact of Bone Marrow miR-21 Expression on Acute Myeloid Leukemia T Lymphocyte Fragility and Dysfunction
por: Moussa Agha, Douâa, et al.
Publicado: (2020)

Protein kinase D-dependent CXCR4 down-regulation upon BCR triggering is linked to lymphadenopathy in chronic lymphocytic leukaemia
por: Saint-Georges, Stéphane, et al.
Publicado: (2016)

Comments on “How Fragile Are the Results of a Trial? The Fragility Index” by Dettori and Norvell
por: Evaniew, Nathan
Publicado: (2020)

Measurable residual disease in chronic lymphocytic leukemia: expert review and consensus recommendations
por: Wierda, William G., et al.
Publicado: (2021)

Response to “Comments on ‘How Fragile Are the Results of a Trial? The Fragility Index’ by Dettori and Norvell”
por: Dettori, Joseph R., et al.
Publicado: (2020)

Author Index 2021 and Subject Index 2021
Publicado: (2022)

Ibrutinib in previously treated chronic lymphocytic leukemia patients with autoimmune cytopenias in the RESONATE study
por: Montillo, M, et al.
Publicado: (2017)

Outcomes with ibrutinib by line of therapy and post‐ibrutinib discontinuation in patients with chronic lymphocytic leukemia: Phase 3 analysis
por: O'Brien, Susan M., et al.
Publicado: (2019)

Bone strain index in the prediction of vertebral fragility refracture
por: Ulivieri, Fabio Massimo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_flt1ofm0lg0f25pr618bsm6779